110 related articles for article (PubMed ID: 2573371)
21. Prejunctional beta-adrenoceptors in the isolated perfused rat kidney: a comparative study of the beta-blockers tertatolol and propranolol.
Verbeuren TJ; Zonnekeyn LL; Prost JF; Herman AG
Arch Int Pharmacodyn Ther; 1989; 298():183-97. PubMed ID: 2569296
[TBL] [Abstract][Full Text] [Related]
22. Regional hemodynamic effects of the beta-adrenoceptor blockers tertatolol and propranolol in conscious spontaneously hypertensive rats.
Nievelstein HM; Tijssen CM; Smits JF; Struyker-Boudier HA
Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):118-29. PubMed ID: 2876684
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertension.
Calès P; Caillau H; Crambes O; Vinel JP; Desmorat H; Rocher I; Jung L; Urien S; Brouard R; Pascal JP
J Hepatol; 1993 Aug; 19(1):43-50. PubMed ID: 7905493
[TBL] [Abstract][Full Text] [Related]
24. The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
Verbeuren TJ; Zonnekeyn LL; Prost JF; Rochat C; Thomas JR; Herman AG
J Pharmacol Exp Ther; 1988 Aug; 246(2):628-34. PubMed ID: 2900328
[TBL] [Abstract][Full Text] [Related]
25. Reduction of beta-adrenergic receptors can explain the lack of rebound effect after tertatolol withdrawal.
De Blasi A; Pittana PL; Fratelli M; Garattini S
Am J Hypertens; 1989 Nov; 2(11 Pt 2):257S-260S. PubMed ID: 2573373
[TBL] [Abstract][Full Text] [Related]
26. Tertatolol ameliorates renal function in rats with chronic renal failure.
Delaini F; Perico N; Tagliaferri M; Lupini C; Patino O; Remuzzi G; Garattini S
J Pharmacol Exp Ther; 1988 Jul; 246(1):287-93. PubMed ID: 2899165
[TBL] [Abstract][Full Text] [Related]
27. Tertatolol potentiates exercise-induced atrial natriuretic peptide release by increasing atrial diameter in healthy subjects.
Berlin I; Deray G; Lechat P; Maistre G; Landault C; Chermat V; Brouard R; Ressayre C; Puech AJ
Cardiology; 1993; 83 Suppl 1():16-24. PubMed ID: 7903211
[TBL] [Abstract][Full Text] [Related]
28. Systemic and renal haemodynamic effects of angiotensin converting enzyme inhibition by zabicipril in young and in old normal men.
Naeije R; Fiasse A; Carlier E; Opsomer M; Leeman M
Eur J Clin Pharmacol; 1993; 44(1):35-9. PubMed ID: 8436152
[TBL] [Abstract][Full Text] [Related]
29. [Vasodilator effect of tertatolol on isolated rat kidney].
Stephan D; Barthelmebs M; Rochat C; Imbs JL
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1211-3. PubMed ID: 2573324
[TBL] [Abstract][Full Text] [Related]
30. Effect of tertatolol and of its metabolites and structural analogues in isolated perfused rat kidney vasculature.
Stephan D; Barthelmebs M; Krieger JP; Decker N; Rochat C; Imbs JL
J Cardiovasc Pharmacol; 1990 Aug; 16(2):338-46. PubMed ID: 1697392
[TBL] [Abstract][Full Text] [Related]
31. Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects.
Berlin I; Lechat P; Deray G; Landault C; Maistre G; Chermat V; Brouard R; Ressayre C; Puech AJ
Eur J Clin Pharmacol; 1993; 44(2):127-33. PubMed ID: 8095894
[TBL] [Abstract][Full Text] [Related]
32. Systemic and renal hemodynamic responses to carvedilol and metoprolol in hypertensive renal transplant patients.
Leeman M; Vereerstraeten P; Uytdenhoef M; Degaute JP
J Cardiovasc Pharmacol; 1993 Nov; 22(5):706-10. PubMed ID: 7506322
[TBL] [Abstract][Full Text] [Related]
33. Interaction of tertatolol with rifampicin and ranitidine pharmacokinetics and antihypertensive activity.
Kirch W; Milferstädt S; Halabi A; Rocher I; Efthymiopoulos C; Jung L
Cardiovasc Drugs Ther; 1990 Apr; 4(2):487-91. PubMed ID: 1981019
[TBL] [Abstract][Full Text] [Related]
34. Selective infusion of tertatolol into the renal artery induces a local vasodilator effect in humans. Demonstration by the continuous thermodilution method.
Nitenberg A; Prost JF; Joussen JM; Blanchet F; Dutray-Dupagne C
Am J Hypertens; 1989 Nov; 2(11 Pt 2):228S-232S. PubMed ID: 2818875
[TBL] [Abstract][Full Text] [Related]
35. [Tertatolol--characteristics of the drug].
Tomaszewski R; Kliz J
Wiad Lek; 1992 Mar; 45(5-6):196, 200, 204 passim. PubMed ID: 1360731
[No Abstract] [Full Text] [Related]
36. Antihypertensive effects of tertatolol. A comparative study versus atenolol.
Mota JC; Carrageta MD; Felix S; Nunes AM; Jobbé-Duval M
Am J Hypertens; 1989 Nov; 2(11 Pt 2):284S-288S. PubMed ID: 2573377
[TBL] [Abstract][Full Text] [Related]
37. Role of baroreflex activation in the regional hemodynamic effects of the beta-blockers tertatolol and propranolol in conscious spontaneously hypertensive rats.
Struyker-Boudier HA; van Essen H; Nievelstein HM; Smits JF
Am J Nephrol; 1986; 6 Suppl 2():25-9. PubMed ID: 2879469
[TBL] [Abstract][Full Text] [Related]
38. Overview of novel renal properties of tertatolol.
Guillet C
Cardiology; 1993; 83 Suppl 1():64-9. PubMed ID: 7903218
[TBL] [Abstract][Full Text] [Related]
39. Long-term renal vasodilator effect of the beta-adrenoceptor blocker tertatolol in conscious spontaneously hypertensive rats.
Nievelstein HN; Tyssen CM; Smits JF; Struyker-Boudier HA
J Cardiovasc Pharmacol; 1988 Aug; 12(2):252-4. PubMed ID: 2459558
[TBL] [Abstract][Full Text] [Related]
40. Effects of long-term antihypertensive treatment with tertatolol on diastolic function in hypertensive patients with and without left ventricular hypertrophy.
Trimarco B; DeLuca N; Rosiello G; Ricciardelli B; Marchegiano R; Condorelli G; Raponi M; Condorelli M
Am J Hypertens; 1989 Nov; 2(11 Pt 2):278S-283S. PubMed ID: 2573376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
